fluorouracil has been researched along with Keratoacanthoma in 58 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Keratoacanthoma: A benign, non-neoplastic, usually self-limiting epithelial lesion closely resembling squamous cell carcinoma clinically and histopathologically. It occurs in solitary, multiple, and eruptive forms. The solitary and multiple forms occur on sunlight exposed areas and are identical histologically; they affect primarily white males. The eruptive form usually involves both sexes and appears as a generalized papular eruption.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective was to evaluate the efficacy of Er:YAG laser surgery combined with topical 5-fluorouracil treatment in a case of recurrent giant keratoacanthoma." | 7.72 | Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg. ( Elsner, P; Fuchs, S; Thiele, JJ; Ziemer, M, 2004) |
| "Keratoacanthomas (KAs) in 14 patients were treated with 20% fluorouracil ointment, two or three times daily, for two to four weeks." | 7.66 | Treatment of keratoacanthoma with topical application of fluorouracil. ( Arrott, JW; Diakon, NC; Goette, DK; Horn, RT; Odom, RB, 1982) |
| "Forty-one keratoacanthomas (KA) occurring in thirty patients were treated with weekly intralesional injections of 5-fluorouracil (5-FU)." | 7.66 | Successful treatment of keratoacanthoma with intralesional fluorouracil. ( Goette, DK; Odom, RB, 1980) |
| "Fourteen patients with 26 keratoacanthomas (KA) were treated weekly with intralesional injections of fluorouracil." | 7.66 | Treatment of keratoacanthomas with intralesional fluorouracil. ( Goette, DK; Odom, RB, 1978) |
| "In the last two years thirteen patients with keratoacanthomas were treated with 5% f-fluorouracil ointment at the Department of Dermatology II of the University of Vienna." | 7.65 | [The local treatment of the keratoacanthoma with 5-fluorouracil]. ( Ebner, H; Mischer, P, 1975) |
| "Differentiating a KA from a squamous cell carcinoma (SCC) is important for treatment implications but is often challenging." | 6.61 | Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature ( Doerfler, L; Hanke, CW, 2019) |
| "Keratoacanthoma is a common, benign cutaneous neoplasm that displays rapid growth on sun-exposed skin." | 5.31 | Topical 5-fluorouracil as primary therapy for keratoacanthoma. ( Gray, RJ; Meland, NB, 2000) |
| "Keratoacanthoma is a benign tumor; however, it may cause massive destruction of normal tissue during its rapid growth phase." | 5.27 | Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. ( Hanke, CW; Parker, CM, 1986) |
| "A keratoacanthoma is a benign epithelial growth most often found in sun-exposed skin of the elderly." | 5.26 | Treatment of multiple keratoacanthomas with intralesional fluorouracil. ( Eubanks, SW; Gentry, RH; May, DL; Patterson, JW, 1982) |
| " Keratoacanthomas had high cure rates with intralesional agents: 98% for 5FU, 91% for methotrexate, 100% for bleomycin, 100% for IFN alpha (α)-2, 83% for IFN α-2a, and 100% for IFN α-2b." | 4.89 | Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. ( Chitwood, K; Cohen, G; Etzkorn, J, 2013) |
| "The objective was to evaluate the efficacy of Er:YAG laser surgery combined with topical 5-fluorouracil treatment in a case of recurrent giant keratoacanthoma." | 3.72 | Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg. ( Elsner, P; Fuchs, S; Thiele, JJ; Ziemer, M, 2004) |
| "Keratoacanthomas (KAs) in 14 patients were treated with 20% fluorouracil ointment, two or three times daily, for two to four weeks." | 3.66 | Treatment of keratoacanthoma with topical application of fluorouracil. ( Arrott, JW; Diakon, NC; Goette, DK; Horn, RT; Odom, RB, 1982) |
| "Successful management of keratoacanthomas and basal-cell epitheliomas by intralesional injections of 5-fluorouracil is reported." | 3.66 | Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU). ( Kurtis, B; Rosen, T, 1980) |
| "In the last two years thirteen patients with keratoacanthomas were treated with 5% f-fluorouracil ointment at the Department of Dermatology II of the University of Vienna." | 3.65 | [The local treatment of the keratoacanthoma with 5-fluorouracil]. ( Ebner, H; Mischer, P, 1975) |
| "Differentiating a KA from a squamous cell carcinoma (SCC) is important for treatment implications but is often challenging." | 2.61 | Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature ( Doerfler, L; Hanke, CW, 2019) |
| "Keratoacanthomas are rapidly growing neoplasms of squamous epithelium." | 1.56 | Successful non-operative treatment of eruptive keratoacanthomas refractory to excision. ( Neill, BC; Seger, EW; Tarantino, IS; Wang, T, 2020) |
| "Keratoacanthoma is a common, benign cutaneous neoplasm that displays rapid growth on sun-exposed skin." | 1.31 | Topical 5-fluorouracil as primary therapy for keratoacanthoma. ( Gray, RJ; Meland, NB, 2000) |
| "Keratoacanthoma is a benign tumor; however, it may cause massive destruction of normal tissue during its rapid growth phase." | 1.27 | Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. ( Hanke, CW; Parker, CM, 1986) |
| "A keratoacanthoma is a benign epithelial growth most often found in sun-exposed skin of the elderly." | 1.26 | Treatment of multiple keratoacanthomas with intralesional fluorouracil. ( Eubanks, SW; Gentry, RH; May, DL; Patterson, JW, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (60.34) | 18.7374 |
| 1990's | 2 (3.45) | 18.2507 |
| 2000's | 7 (12.07) | 29.6817 |
| 2010's | 6 (10.34) | 24.3611 |
| 2020's | 8 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Hamad, J | 1 |
| Jolly, PS | 1 |
| Gil-Lianes, J | 1 |
| Morgado-Carrasco, D | 1 |
| Marka, A | 2 |
| Rodgers, D | 1 |
| Zelaya Castillo, L | 1 |
| Hoyt, B | 1 |
| Chapman, M | 1 |
| Carter, J | 1 |
| Seger, EW | 1 |
| Tarantino, IS | 1 |
| Neill, BC | 1 |
| Wang, T | 1 |
| Hoegler, KM | 1 |
| Schleichert, RA | 1 |
| Elston, DM | 1 |
| Maghfour, J | 1 |
| Kuraitis, D | 1 |
| Murina, A | 1 |
| Kiss, N | 1 |
| Avci, P | 1 |
| Bánvölgyi, A | 1 |
| Lőrincz, K | 1 |
| Szakonyi, J | 1 |
| Gyöngyösi, N | 1 |
| Fésűs, L | 1 |
| Lee, G | 1 |
| Wikonkál, N | 1 |
| Hoyt, BS | 1 |
| Linos, K | 1 |
| Vidal, NY | 1 |
| Que, SKT | 1 |
| Compton, LA | 1 |
| Schmults, CD | 1 |
| Silva, E | 1 |
| Estébanez, A | 1 |
| Martín, JM | 1 |
| Monteagudo, C | 1 |
| Montesinos, E | 1 |
| Doerfler, L | 1 |
| Hanke, CW | 3 |
| LaPresto, L | 1 |
| Cranmer, L | 1 |
| Morrison, L | 1 |
| Erickson, CP | 1 |
| Curiel-Lewandrowski, C | 1 |
| Chitwood, K | 1 |
| Etzkorn, J | 1 |
| Cohen, G | 1 |
| Hadley, JC | 1 |
| Tristani-Firouzi, P | 1 |
| Florell, SF | 1 |
| Bowen, GM | 1 |
| Hadley, ML | 1 |
| Moore, AY | 1 |
| ROSSMAN, RE | 1 |
| KNOX, JM | 1 |
| FREEMAN, RG | 1 |
| LANE, M | 1 |
| KLEIN, E | 1 |
| HELM, F | 1 |
| MILGROM, H | 1 |
| STOLL, HL | 1 |
| TRAENKLE, HL | 1 |
| Divers, AK | 1 |
| Correale, D | 1 |
| Lee, JB | 1 |
| Thiele, JJ | 1 |
| Ziemer, M | 1 |
| Fuchs, S | 1 |
| Elsner, P | 1 |
| Yuge, S | 1 |
| Godoy, DA | 1 |
| Melo, MC | 1 |
| Sousa, DS | 1 |
| Soares, CT | 1 |
| Leonard, AL | 1 |
| Rogers, M | 1 |
| Goette, DK | 4 |
| Heine, KG | 1 |
| Odom, RB | 3 |
| Arrott, JW | 1 |
| Diakon, NC | 1 |
| Horn, RT | 1 |
| Hochart, G | 1 |
| Piette, F | 1 |
| Eubanks, SW | 1 |
| Gentry, RH | 1 |
| Patterson, JW | 1 |
| May, DL | 1 |
| Kurtis, B | 1 |
| Rosen, T | 1 |
| Singal, A | 1 |
| Mohanty, S | 1 |
| Bhattacharya, SN | 1 |
| Baruah, MC | 1 |
| Singh, N | 1 |
| Agarwal, M | 1 |
| Chander, R | 1 |
| Karmakar, S | 1 |
| Walia, R | 1 |
| Gray, RJ | 1 |
| Meland, NB | 1 |
| Ebner, H | 3 |
| Mischer, P | 2 |
| Jansen, GT | 1 |
| Prutkin, L | 3 |
| Larson, PO | 1 |
| Bergin, DJ | 1 |
| Lapins, NA | 1 |
| Deffer, TA | 1 |
| Heid, E | 1 |
| Cobb, MW | 1 |
| Pellegrini, AE | 1 |
| Parker, CM | 1 |
| Padilla, H | 1 |
| Westburg, SP | 1 |
| Stone, OJ | 1 |
| Swart-Bruinsma, WA | 1 |
| Herrmann, WA | 1 |
| Gleason, MC | 1 |
| Uthida-Tanaka, AM | 1 |
| Nakamura, S | 1 |
| de Britto-Costa, R | 1 |
| de Tavares Mello, E | 1 |
| Basset, A | 1 |
| Grosshans, E | 1 |
| Maleville, J | 1 |
| Grupper, C | 1 |
| De Moragas, JM | 1 |
| Gimenez-Camarasa, JM | 1 |
| Midana, A | 1 |
| Leigheb, G | 1 |
| Almeida Gonçalves, JC | 1 |
| De Noronha, T | 1 |
| Nazzaro, P | 1 |
| Anderson, FE | 1 |
| Johnson, AM | 1 |
| Havyatt, MT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase I, Dual Arm, Open-Label, Trial of Intralesional 5-Fluorouracil (5FU) and Intralesional 5FU Combined With Topical Imiquimod in Patients With Squamous Cell Carcinoma (SCC) of the Lower Extremities[NCT03370406] | Phase 1 | 30 participants (Anticipated) | Interventional | 2018-08-03 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for fluorouracil and Keratoacanthoma
| Article | Year |
|---|---|
Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Topics: Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; | 2021 |
Intralesional therapy for the treatment of keratoacanthoma.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Dermatologic Agents; Fluorouracil; Humans; Injectio | 2019 |
Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature
Topics: Antineoplastic Agents; Biopsy; Bleomycin; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; In | 2019 |
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; | 2013 |
Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Topics: Administration, Cutaneous; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic | 2009 |
Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge.
Topics: Aged; Dermatologic Agents; Fluorouracil; Humans; Immunosuppressive Agents; Isotretinoin; Keratoacant | 2004 |
52 other studies available for fluorouracil and Keratoacanthoma
| Article | Year |
|---|---|
Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Topics: Carcinoma, Squamous Cell; Cytoreduction Surgical Procedures; Fluorouracil; Humans; Keratoacanthoma; | 2021 |
RF - Intralesional 5-Fluorouracil in the Treatment of Nonmelanoma Skin Cancer.
Topics: Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intralesional; Keratoacanthoma; Skin Neopla | 2023 |
Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Injections, Intralesional; Keratoacanthoma; Retrospe | 2023 |
Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
Topics: Aged; Antimetabolites, Antineoplastic; Arm; Fluorouracil; Humans; Injections, Intralesional; Keratoa | 2020 |
Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
Topics: Dermatologic Agents; Fluorouracil; Humans; Injections, Intralesional; Keratoacanthoma; Methotrexate; | 2020 |
Medical therapy for keratoacanthomas.
Topics: Fluorouracil; Humans; Keratoacanthoma; Methotrexate | 2020 |
Eruptive Keratoacanthomas of the Upper Extremities Successfully Treated With Intralesional Corticosteroid After Multiple Treatment Failures.
Topics: Acitretin; Administration, Oral; Biopsy; Drug Resistance; Female; Fluorouracil; Forearm; Glucocortic | 2020 |
Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Topics: Adult; Biopsy, Needle; Carcinoma, Squamous Cell; Cohort Studies; Databases, Factual; Diagnosis, Diff | 2019 |
Keratoacanthoma centrifugum marginatum after photodynamic therapy with good response to oral retinoids and topical 5-fluorouracil.
Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Dermatologic Agents; Female; Fluorouraci | 2019 |
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
Topics: Acitretin; Aged; Antineoplastic Agents; Drug Therapy, Combination; Fluorouracil; Humans; Indoles; In | 2013 |
Case series of multiple recurrent reactive keratoacanthomas developing at surgical margins.
Topics: Acitretin; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Fluorou | 2009 |
CLINICOPATHOLOGIC CONFERENCE.
Topics: Black People; Bromides; Diagnosis, Differential; Drug Eruptions; Fluorouracil; Granuloma; Humans; Ke | 1964 |
Tumors of the skin. II. Keratoacanthoma; local effct of 5-fluorouracil.
Topics: Fluorouracil; Humans; Keratoacanthoma; Neoplasms; Skin; Skin Neoplasms; Uracil | 1962 |
Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Combined Modality Therapy; Diagnosis, Di | 2004 |
Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil.
Topics: Aged, 80 and over; Dermatologic Agents; Female; Fluorouracil; Humans; Keratoacanthoma; Leg; Methotre | 2006 |
Treatment of giant keratoacanthoma with intralesional 5-fluorouracil.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Gestati | 2006 |
Management of common skin tumours.
Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Dermatitis, Seborrhei | 1980 |
Treatment of keratoacanthoma with topical fluorouracil.
Topics: Administration, Topical; Aged; Female; Fluorouracil; Humans; Keratoacanthoma; Male; Middle Aged | 1983 |
Treatment of multiple keratoacanthomas with fluorouracil.
Topics: Arm; Fluorouracil; Hand Dermatoses; Humans; Keratoacanthoma; Male; Middle Aged; Skin Diseases | 1983 |
Treatment of keratoacanthoma with topical application of fluorouracil.
Topics: Administration, Topical; Adult; Aged; Dermatitis, Contact; Female; Fluorouracil; Humans; Keratoacant | 1982 |
[Treatment of a keratoacanthoma of the upper eyelid by intra-lesional injection of fluorouracil].
Topics: Adolescent; Eyelid Diseases; Female; Fluorouracil; Humans; Keratoacanthoma | 1982 |
Treatment of multiple keratoacanthomas with intralesional fluorouracil.
Topics: Fluorouracil; Humans; Keratoacanthoma; Male; Middle Aged; Recurrence; Skin Diseases | 1982 |
Treatment of cutaneous neoplasms by intralesional injections of 5-fluorouracil (5-FU).
Topics: Adult; Carcinoma, Basal Cell; Fluorouracil; Humans; Injections, Intradermal; Keratoacanthoma; Male; | 1980 |
Successful treatment of keratoacanthoma with intralesional fluorouracil.
Topics: Adult; Aged; Female; Fluorouracil; Humans; Injections, Intradermal; Keratoacanthoma; Male; Middle Ag | 1980 |
Unusual multiple keratoacanthoma in a child successfully treated with 5-fluorouracil.
Topics: Administration, Topical; Antimetabolites, Antineoplastic; Child, Preschool; Fluorouracil; Humans; In | 1997 |
Multiple familial keratoacanthoma of Witten and Zak - A report of three siblings.
Topics: Adult; Antimetabolites, Antineoplastic; Child; Family Health; Female; Fluorouracil; Humans; Keratoac | 1999 |
Topical 5-fluorouracil as primary therapy for keratoacanthoma.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antimetabolites; Fluorouracil; Humans; Keratoacant | 2000 |
[Treatment of keratoacanthoma].
Topics: Age Factors; Aged; Bleomycin; Colchicine; Curettage; Fluorouracil; Humans; Keratoacanthoma; Middle A | 1975 |
Treatment of keratoacanthomas with intralesional fluorouracil.
Topics: Aged; Female; Fluorouracil; Humans; Injections; Keratoacanthoma; Male; Middle Aged | 1978 |
Practical therapy for hyperkeratotic skin lesions.
Topics: Acetates; Aged; Bandages; Callosities; Electrosurgery; Female; Fluorouracil; Foot; Humans; Keratoaca | 1975 |
Inhibition of tumorigenesis by topical application of low doses of vitamin A acid and fluorouracil.
Topics: Administration, Topical; Animals; Benz(a)Anthracenes; Dose-Response Relationship, Drug; Drug Therapy | 1975 |
[The local treatment of the keratoacanthoma with 5-fluorouracil].
Topics: Administration, Topical; Adult; Aged; Diagnosis, Differential; Female; Fluorouracil; Humans; Keratoa | 1975 |
Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery). A review of forty-three cases.
Topics: Aged; Aged, 80 and over; Female; Fluorouracil; Humans; Keratoacanthoma; Male; Microsurgery; Middle A | 1987 |
Intralesional 5-fluorouracil for keratoacanthoma of the eyelid.
Topics: Aged; Aged, 80 and over; Eyelid Diseases; Fluorouracil; Humans; Keratoacanthoma; Male; Middle Aged; | 1986 |
[Keratoacanthoma. New therapeutic possibilities].
Topics: Fluorouracil; Humans; Isotretinoin; Keratoacanthoma; Podophyllin; Tretinoin | 1987 |
Squamous cell carcinoma following fluorouracil-responsive 'keratoacanthoma'.
Topics: Aged; Carcinoma, Squamous Cell; Diagnostic Errors; Fluorouracil; Humans; Keratoacanthoma; Male; Skin | 1987 |
Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
Topics: Adult; Aged; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Injections; Keratoacanthoma | 1986 |
Antitumor activity of vitamin A acid and fluorouracil used in combination on the skin tumor, keratoacanthoma.
Topics: Animals; Antineoplastic Agents; Biopsy; Drug Combinations; Drug Synergism; Ear Neoplasms; Epithelial | 1973 |
[Indications for fluorouracil in dermatology].
Topics: DNA; DNA Replication; Drug Evaluation; Fluorouracil; Humans; Keratoacanthoma; Keratosis; Neoplasms; | 1974 |
Multiple cutaneous squamous cell carcinomas during immunosuppressive therapy.
Topics: Adult; Azathioprine; Carcinoma, Squamous Cell; Fluorouracil; Humans; Hyperplasia; Immunosuppressive | 1973 |
[External treatment with 5-fluorouracil].
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; Ointments; Xeroderma Pig | 1973 |
Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Dermabrasion; Electrosurgery; Fac | 1970 |
[Topical therapy of precancerous lesions and skin carcinomas using a 5-fluorouracil ointment].
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Fluorouracil | 1969 |
[Our experience with the local chemotherapy of cutaneous precancerous conditions, epithelioma and of kerato-acanthoma].
Topics: Colchicine; Diagnosis, Differential; Fluorouracil; Humans; Keratoacanthoma; Ointments; Precancerous | 1970 |
Treatment of keratoacanthomas by local applications of the 5-fluorouracil (5-FU) ointment.
Topics: Adult; Aged; Female; Fluorouracil; Humans; Keratoacanthoma; Male; Middle Aged; Ointments; Skin Neopl | 1970 |
5-fluorouracil ointment in tumors of the skin.
Topics: Aged; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Keratoacanthoma; Keratosis; Male; Middle | 1970 |
5-fluorouracil (5-FU) ointment in the treatment of benign and malignant skin lesions.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; L | 1970 |
5-fluouracil (5-FU) ointment in the treatment of skin tumours and keratoses.
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratoacanthoma | 1970 |
[Dermatologic aspects of cutaneous pseudocancer].
Topics: Colchicine; Diagnosis, Differential; Fluorouracil; Humans; Keratoacanthoma; Podophyllin; Skin Diseas | 1971 |
[Topical cytostatic treatment of epitheliomas with a 5 per cent 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Keratoacanthoma | 1968 |
An ultrastructural study of the keratoacanthoma treated with methotrexate and 5-fluorouracil.
Topics: Animals; Cell Nucleus; Cytoplasm; Endoplasmic Reticulum; Fluorouracil; Keratoacanthoma; Male; Methot | 1968 |
Preliminary studies in the use of 5-fluoro-uracil cream in the treatment of malignant and premalignant skin tumours.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Keratoacanthoma; Keratosis; O | 1969 |